P
Über
CEO at GC Holding AG (appointed October 2024). Former President and CSO at Ferring Pharmaceuticals. Executive positions at Novo Nordisk and AstraZeneca. Over 30 years in microbiome science. Associate Professor at Karolinska Institute and Washington University School of Medicine. MD and PhD in Biochemistry and Clinical Chemistry.
Schwerpunkte
Biotech, Pharmaceuticals, CRISPR Technology, Antimicrobial Resistance, Infectious Disease, Gene Modification
Region
📍 Ansässig in Sweden
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...